Insider · CIK 0001643072

Modig Berndt

Reports to the SEC for 2 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001643072

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-17	PHVSPharvaris N.V.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−300K sh	$35.00	−$10.5M	650,000
2026-09-14	PHVSPharvaris N.V.S Sale	Director, Chief Executive Officer	SSale	−2,291 sh	$39.40	−$90.3K	128,334
2026-08-14	PHVSPharvaris N.V.S Sale	Director, Chief Executive Officer	SSale	−2,292 sh	$34.77	−$79.7K	130,625
2026-07-13	PHVSPharvaris N.V.S Sale	Director, Chief Executive Officer	SSale	−2,292 sh	$34.97	−$80.2K	132,917
2026-06-15	PHVSPharvaris N.V.S Sale	Director, Chief Executive Officer	SSale	−2,191 sh	$31.05	−$68K	135,309
2026-06-15	PHVSPharvaris N.V.S Sale	Director, Chief Executive Officer	SSale	−100 sh	$31.46	−$3,146	135,209
2026-05-18	PHVSPharvaris N.V.S Sale	Director, Chief Executive Officer	SSale	−2,292 sh	$29.22	−$67K	137,500
2026-04-16	PHVSPharvaris N.V.S Sale	Director, Chief Executive Officer	SSale	−2,292 sh	$28.60	−$65.6K	139,792
2026-04-09	PHVSPharvaris N.V.S Sale	Director, Chief Executive Officer	SSale	−23.1K sh	$27.74	−$642K	142,284
2026-04-09	PHVSPharvaris N.V.S Sale	Director, Chief Executive Officer	SSale	−200 sh	$28.41	−$5,683	142,084
2021-04-15	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Director	AAward	+42K sh	—	—	42,000
2020-04-15	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2019-04-15	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Director	AAward	+255K sh	—	—	255,000
2018-03-15	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2017-12-29	Sio Gene Therapies Inc.M Exercise/Conversion	Director	MExercise/Conversion	+77.9K sh	$0.90	+$70.1K	77,914
2017-12-29	Sio Gene Therapies Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−77.9K sh	—	—	7,086
2017-04-28	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	27,000
2016-04-29	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Director	AAward	+47K sh	—	—	47,000

Recent filings

Accepted (ET)
Sep 214
Modig Berndt0001193125-26-396565
SEC(opens sec.gov)
Sep 154
Modig Berndt0001193125-26-391713
SEC(opens sec.gov)
Aug 184
Modig Berndt0001193125-26-354965
SEC(opens sec.gov)
Jul 154
Modig Berndt0001193125-26-304445
SEC(opens sec.gov)
Jun 174
Modig Berndt0001193125-26-274440
SEC(opens sec.gov)
May 204
Modig Berndt0001193125-26-232892
SEC(opens sec.gov)
Apr 204
Modig Berndt0001193125-26-163713
SEC(opens sec.gov)
Apr 104
Modig Berndt0001193125-26-150954
SEC(opens sec.gov)
Apr 194
Modig Berndt0001636050-21-000047
SEC(opens sec.gov)
Apr 174
Modig Berndt0001209191-20-025023
SEC(opens sec.gov)
Apr 174
Modig Berndt0001209191-19-025190
SEC(opens sec.gov)
Mar 164
Modig Berndt0001209191-18-020367
SEC(opens sec.gov)
Jan 34
Modig Berndt0001104659-18-000368
SEC(opens sec.gov)
May 24
Axovant Sciences Ltd.0001209191-17-029472
SEC(opens sec.gov)
May 34
Axovant Sciences Ltd.0001643072-16-000004
SEC(opens sec.gov)

Companies

Address

1 CRANBERRY HILL SUITE 400

LEXINGTON, MA, 02421